Delivery Order SPE2DB22D2214-SPE2DB24FS6TC

Award Date 9/17/24
Potential Completion Date 9/18/24
Potential Value $17K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of DUPIXENT 300 MG/2 ML SYRINGE 2ML, a specialty pharmaceutical product, with a ceiling value of $7,265.49 and a completion date of March 24, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,831.91, is for the provision of DUPIXENT 300 MG/2 ML SYRINGE 2ML, a specialty pharmaceutical product. The contract type is Firm Fixed Price, with a period of performance through December 12, 2023. This delivery order is part of a larger Indefinite Delivery Contract...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of DUPIXENT 300 MG/2 ML SYRINGE 2ML, a specialty pharmaceutical product, with a Ceiling Value of $5,389.29. The contract has a period of performance through March 5, 2024. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of DUPIXENT 300 MG/2 ML SYRINGE 2ML. The delivery order has a ceiling value of $9,472.80 and an ultimate completion date of May 22, 2024. The contract is a Firm Fixed Price arrangement. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the pharmaceutical product DUPIXENT 300 MG/2 ML SYRINGE 2ML, with a ceiling value of $4,725.85. The contract is a Firm Fixed Price Delivery Order, with a period of performance through November 29, 2023. This order is part of a larger Indefinite Delivery Contract (IDC) between...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is valued at $3,418.92 and has an ultimate completion date of January 22, 2025. The contract provides the DLA with 4566992149 DUPIXENT 300 MG/2 ML SYRINGE 2ML, a specialty pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,709.46 contract is for the supply of DUPIXENT 300 MG/2 ML SYRINGE 2ML, a pharmaceutical product, with a period of performance through March 19, 2025. The award is not designated as a set-aside contract. This delivery order appears to be part of a larger Indefinite Delivery Contract (IDC) that...
This is a delivery order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of DUPIXENT 300 MG/2 ML SYRINGE 2ML. The award has a ceiling value of $14,708.32 and a period of performance through January 24, 2025. The contract type is Firm Fixed Price. This award is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued at $999,999,999 and running...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,521.83, is for the delivery of DUPIXENT 300 MG/2 ML SYRINGE 2ML, a specialty pharmaceutical product. The contract type is Delivery Order with a Firm Fixed Price pricing structure, and the ultimate completion date is November 6, 2024. This award is associated with a larger Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of DUPIXENT 300 MG/2 ML SYRINGE 2ML, a specialty medication. The delivery order has a ceiling value of $22,835.96 and a completion date of April 2, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
  • SPE2DB22D2214
    Indefinite Delivery Contract
  • SPE2DB22D2214-SPE2DB24FS6TC
    Delivery Order

This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of DUPIXENT 300 MG/2 ML SYRINGE 2ML. The contract has a Firm Fixed Price pricing type and a ceiling value of $16,639.11. The ultimate completion date is September 18, 2024. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 and running through December 2025. The IDC enables the DLA to efficiently procure a comprehensive range of medical commodities, including pharmaceuticals and medical supplies, to support military treatment programs and facilities worldwide. This contract award does not have a set-aside designation.

Generated 12/17/24, 9:29 AM